Anidulafungin | 99.88%(HPLC) | In Stock

Anidulafungin, an echinocandin derivative, inhibits glucan synthase activity, used as an antifungal drug.

Anidulafungin Chemical Structure

CAS: 166663-25-8

Selleck's Anidulafungin has been cited by 13 Publications

1 Customer Review

Purity & Quality Control

Batch: Purity: 99.88%

99.88

Anidulafungin Related Products

Related Products	Cycloheximide Caspofungin (MK-0991) Acetate Micafungin Sodium Tolnaftate Terbinafine Miconazole Nitrate Atovaquone Miconazole Terbinafine HCl Neticonazole Amorolfine HCl Tioconazole Sulconazole Nitrate Clioquinol Pseudolaric Acid B Butoconazole Butylparaben Climbazole Thimerosal Flucytosine (5-Fluorocytosine) Terconazole Isavuconazole Neticonazole Hydrochloride Juglone Sertaconazole nitrate Bifonazole	Click to Expand
Related Compound Libraries	Anti-infection Compound Library Antibiotics compound Library Antiviral Compound Library Anti-parasitic Compound Library Gut Microbial Metabolite Library	Click to Expand

Choose Selective Fungal Inhibitors

Biological Activity

Description

Anidulafungin, an echinocandin derivative, inhibits glucan synthase activity, used as an antifungal drug.

Targets

glucan synthase ^[1]

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2024-01-11)
NCT04876716	Recruiting	Invasive Aspergillosis	Erasmus Medical Center\|ZonMw: The Netherlands Organisation for Health Research and Development\|Stichting Hemato-Oncologie voor Volwassenen Nederland	May 11 2021	Phase 3
NCT02021123	Completed	Obesity Morbid	Radboud University Medical Center	August 2014	Phase 4
NCT01236261	Completed	Fungemia	Fundacion SEIMC-GESIDA\|Astellas Pharma Inc\|Gilead Sciences\|Merck Sharp & Dohme LLC\|Pfizer	March 2013	--
NCT01734525	Completed	Candidemia	Universidade Federal do Rio de Janeiro	November 2012	Phase 4
NCT01188759	Withdrawn	Aspergillosis\|Invasive Pulmonary Aspergillosis\|Neuroaspergillosis	Pfizer	May 2012	Phase 3

References
[1] Zhanel GG, et al. Antimicrob Agents Chemother, 1997,41(4):863-5.

References

[1] Zhanel GG, et al. Antimicrob Agents Chemother, 1997,41(4):863-5.

Chemical Information & Solubility

Molecular Weight	1140.24	Formula	C₅₈H₇₃N₇O₁₇
CAS No.	166663-25-8	SDF	Download Anidulafungin SDF
Smiles	CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)O)O
Storage (From the date of receipt)	3 years -20°C(in the dark) powder	Storage of Stock Solutions Aliquot the stock solutions to avoid repeated freeze-thaw cycles	1 year-80°Cin solvent
Storage (From the date of receipt)	3 years -20°C(in the dark) powder		1 month-20°Cin solvent

In vitro
Batch:

DMSO : 100 mg/mL ( (87.7 mM)； Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 8 mg/mL

Water : Insoluble

Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.

In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
=	×	×

Dilution Calculator Molecular Weight Calculator

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):